Tirzepatide, currently marketed by Eli Lilly (NYSE:LLY) as Mounjaro and Zepbound for diabetes and weight loss, respectively, ...
TennCare, Tennessee's Medicaid program, seeks a $975 million budget boost driven in large part by rising costs from drugs ...
In the United Kingdom, the government is hoping weight loss drugs might improve public finances, eyeing their use to help ...
But for diabetes and obesity drugs like Ozempic and Zepbound, known as GLP-1s, cheaper copycats emerged almost ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback